RxNorm Semantic Concepts Index - 175
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "175".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 17500 | 1-hydroxymethyltriazolam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17500 | 1-hydroxymethyltriazolam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17500 | 1-hydroxymethyltriazolam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1750149 | Antibody to desmoglein-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1750149 | Antibody to desmoglein-3 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1750149 | Antibody to desmoglein-3 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1750149 | Antibody to desmoglein-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17510 | Alpha-ketoglutarate decarboxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17510 | Alpha-ketoglutarate decarboxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17510 | Alpha-ketoglutarate decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17511 | alpha-ketoglutaric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 175128 | Vaseretic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 17516 | Arabinosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17516 | Arabinosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17516 | Arabinosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17517 | Alpha-L-rhamnosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17517 | Alpha-L-rhamnosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175184 | Fioricet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1752 | Bromelains | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1752 | Bromelains | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1752 | Bromelains | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1752 | Bromelains | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1752 | Bromelains | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1752 | Bromelains | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1752 | Bromelains | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 17528 | Alpha-methylene gamma-butyrolactone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17528 | Alpha-methylene gamma-butyrolactone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1753 | Bromhexine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1753 | Bromhexine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1753 | Bromhexine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1753 | Bromhexine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1753 | Bromhexine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 175320 | Polysialic-acid O-acetyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175320 | Polysialic-acid O-acetyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17541 | Alpha-methyltyrosine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17541 | Alpha-methyltyrosine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17541 | Alpha-methyltyrosine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 175466 | 3-alpha-hydroxyglycyrrhetinate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175466 | 3-alpha-hydroxyglycyrrhetinate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17547 | N-Acetyl-alpha-galactosaminidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17547 | N-Acetyl-alpha-galactosaminidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17548 | Alpha-N-acetylglucosaminidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17548 | Alpha-N-acetylglucosaminidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17558 | Alpha neoendorphin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17558 | Alpha neoendorphin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17566 | Alpha-pinene oxide lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17566 | Alpha-pinene oxide lyase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17566 | Alpha-pinene oxide lyase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175669 | Carba mix | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175669 | Carba mix | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175669 | Carba mix | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17569 | Alpha-sarcin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17569 | Alpha-sarcin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17569 | Alpha-sarcin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17569 | Alpha-sarcin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1757 | Bromisoval | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1757 | Bromisoval | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1757 | Bromisoval | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1757105 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1757105 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1757105 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1757105 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1757105 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175825 | 12-beta-hydroxysteroid dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175825 | 12-beta-hydroxysteroid dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17583 | Alfadolone acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17583 | Alfadolone acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17583 | Alfadolone acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175846 | Demethylmacrocin O-methyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175846 | Demethylmacrocin O-methyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 17593 | Alternansucrase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17593 | Alternansucrase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175955 | Questin oxygenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175955 | Questin oxygenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175955 | Questin oxygenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 175956 | DHCA-CoA ligase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175956 | DHCA-CoA ligase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175956 | DHCA-CoA ligase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17599 | Altizide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 17599 | Altizide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 17599 | Altizide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 17599 | Altizide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 175990 | Factor V-activating proteinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 175990 | Factor V-activating proteinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 175990 | Factor V-activating proteinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 175990 | Factor V-activating proteinase | Full form of descriptor (FN) | NO |